You are here

  • Home
  • Archive
  • Volume 3, Issue 2
  • Sodium selenate as a disease-modifying treatment for mild–moderate Alzheimer’s disease: an open-label extension study

Article metrics

Article menu

Download PDFPDF

Original research
Sodium selenate as a disease-modifying treatment for mild–moderate Alzheimer’s disease: an open-label extension study

 

Online download statistics by month:

Online download statistics by month: December 2021 to May 2023

AbstractFullPdf
Dec 202111011230
Jan 202220921163
Feb 2022868819
Mar 202212012126
Apr 202210110428
May 202220721475
Jun 202213213536
Jul 202211611618
Aug 202211812313
Sep 202211311317
Oct 202213513518
Nov 2022676712
Dec 2022656920
Jan 2023444611
Feb 2023818520
Mar 202319119515
Apr 2023677018
May 202331231729
Total22742321468